课题基金 / 基金详情

Mechanisms ot Maternal Immune Tolerence

Mechanisms ot Maternal Immune Tolerence
母体免疫耐受机制
批准号:
6619506
负责人:
LAURIE Hollis GLIMCHER
金额:
$40.5万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2007-05-31

项目摘要

项目成果

LAURIE Hollis GLIMCHER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):异体胎儿如何避免母体
英文摘要
Description (provided by applicant): How the allogeneic fetus avoids maternal immune rejection during pregnancy is not only one of the outstanding questions in contemporary immunology, but is also now recognized to have major clinical relevance towards diseases such as recurrent spontaneous abortion and preeclampsia, as well as application towards organ transplantation. Although it is generally accepted that the maternal immune system is ?aware? that the fetus and placenta exist, studies to date have only focused on CD8+ T cells and B cells, and thus have not addressed the behavior of potentially reactive CD4+ T helper cells, the lymphocyte subset likely to play the most important role in any form of antigen-specific tolerance induction. Here, we will directly characterize the responses of both maternal CD4+ and CD8+ T cells towards a placentally expressed antigen, taking advantage of transgenic mice we have recently made that express the well-characterized model antigen ovalbumin in placental tissues (Aim 1). The use of this system will also allow us to test whether maternal tolerance towards the fetus and placenta is local or systemic, and whether it involves attenuation of affector or effector arms of the immune response. The nature of antigen presenting cells (APCs) in the pregnant uterus is another area that is virtually unexplored, despite the central role of these cells in regulating tolerance induction. Thus, we will characterize the behavior and antigen-presenting capacity of APCs in the pregnant uterus, focusing on resident dendritic cells, which have been completely uncharacterized in mice (Aim 2). Lastly, we describe the generation of novel transformed murine trophoblast cell lines directly from cultured trophoblast stem cells. Since these transformed trophoblasts are rejected in non-pregnant allogeneic mice following subcutaneous injection, they provide a powerful reagent for dissecting the relative importance of trophoblasts, the uterine environment, and the hormonal state of pregnancy in establishing maternal tolerance (Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a pragmatic guide to implementing social risk referrals: A partnership between Caring Health Center (CHC) and the Implementation Science Center for Cancer
  • 批准号:
    10822141
  • 项目类别:
  • 资助金额:
    $22.47万
  • 财政年份:
    2023
  • 负责人:
    LAURIE Hollis GLIMCHER
  • 依托单位:
Understanding the impact of an EHR-integrated hereditary cancer risk assessment application on patient-provider communication
  • 批准号:
    10831167
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2023
  • 负责人:
    LAURIE Hollis GLIMCHER
  • 依托单位:
Real-World Molecularly Targeted Treatment Registry (MaTTeR): a Pilot Study to Enrich CCDI Data Utilizing Directed Electronic Medical Record (EMR) Extraction
  • 批准号:
    10878384
  • 项目类别:
  • 资助金额:
    $49.59万
  • 财政年份:
    2023
  • 负责人:
    LAURIE Hollis GLIMCHER
  • 依托单位:
Repurposing Bruton's tyrosine kinase (BTK) inhibitors to reverse immunosuppression in high-grade serous ovarian cancer (HGSC)
  • 批准号:
    10661823
  • 项目类别:
  • 资助金额:
    $8.9万
  • 财政年份:
    2022
  • 负责人:
    LAURIE Hollis GLIMCHER
  • 依托单位:
海外基金